DNA-dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards

Blood

Volumn 92, Issue 7, 1998, Pages 2213-2219

  Muller, Catherine ^b   Christodoulopoulos, Garyfallia ^b   Salles, Bernard ^b   Panasci, Lawrence ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CHLORMETHINE DERIVATIVE; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; DNA BINDING; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME MECHANISM; PRIORITY JOURNAL;

EID: 0032189843     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2213     Document Type: Article

References (38)

1. Ross WE, Ewig RAG, Kohn KW: Differences between melphalan and nitrogen mustard in the formation and removal of cross-links. Cancer Res 38:1502, 1978
2. Zwelling LA, Michaels S, Schwartz H, Dobson PP, Kohn KW: DNA crosslinking as an indicator of sensitivity and resistance of mouse L-1210 leukemia to cis-diamminedichloroplatinum (II) and L-phenylalanine nitrogen mustard. Cancer Res 41:640, 1981
3. Hansson JA, Lewensohn R, Ringborg U, Nilson B: Formation and removal of crosslinks induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells. Cancer Res 47:2631, 1987
4. Plunkett W, Begleiter A, Liliemark JO, Reed JC: Why do drugs work in CLL? Leuk Lymphoma 22:1, 1996 (suppl 2)
5. Torres-Garcia SJ, Cousineau L, Caplan S, Panasci L: Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links. Biochem Pharmacol 38:3122, 1989
6. Bramson J, McQuillan A, Aubin R, Alaoui-Jamali M, Batist G, Christodoulopoulos G, Panasci LC: Nitrogen mustard resistant B cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance. Mutation Res 336:269, 1995
7. Sancar A: DNA excision repair. Annu Rev Biochem 65:43, 1996
8. Thompson LH: Evidence that mammalian cells possess homologous recombinational repair pathways. Mutation Res 363:77, 1996
9. Bramson J, McQuillan A, Panasci LC: DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance. Cancer Lett 90:139, 1995
10. Barret JM, Calsou P, Laurent G, Salles B: DNA repair activity in protein extracts of fresh human malignant lymphoid cells. Mol Pharmacol 49:766, 1996
11. Muller C, Salles B: Regulation of DNA-dependent protein kinase activity in leukemic cells. Oncogene 15:2343, 1997
12. Blier PR, Griffith AJ, Craft J, Hardin JA: Binding of Ku protein to DNA-Measurement of affinity for ends and demonstration of binding to nicks. J Biol Chem 268:7594, 1993
13. Falzon M, Fewell JW, Kuff EL: EBP-80, a transcription factor closely resembling the human autoantigen Ku, recognizes single-to-double-strand transitions in DNA. J Biol Chem 268:10546, 1993
14. Minori T, Hardin JA: Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem 261:10375, 1986
15. Gottlieb TM, Jackson SP: The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen. Cell 72:131, 1993
16. Lees-Miller SP, Chen YR, Anderson CW: Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53 and the human Ku autoantigen. Mol Cell Biol 10:6472, 1990
17. Jin S, Inoue S, Weaver DT: Functions of the DNA dependent protein kinase. Cancer Surv 29:221, 1997
18. Peterson SR, Kurimasa A, Oshimura M, Dynan WS, Bradbury EM, Chen DJ: Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc Natl Acad Sci USA 92:3171, 1995
19. Taccioli GE, Rathbun G, Oltz E, Stamato T, Jeggo PA, Alt F: Impairment of V(D)J recombination in double-strand break repair mutants. Science 265:1142, 1993
20. Caldecott K, Jeggo P: Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents. Mutation Res 255:111, 1991
21. Tanaka T, Yamagami T, Oka Y, Nomura T, Sugiyama H: The scid mutation in mice causes defects in the repair system for both double-strand DNA breaks and DNA cross-links. Mutation Res 288:277, 1983
22. Binet JL, Auquier A, Dighiero G: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate analysis. Cancer 48:198, 1981
23. Panasci L, Henderson D, Torres-Garcia SJ, Skalski V, Caplan S, Hutchinson M: Transport, metabolism and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia. Cancer Res 48:1972, 1988
24. Lees-Miller P, Godbout R, Chan DW, Weinfeld M, Day RS III, Barron GM, Allalunis-Turner J: Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267: 1183, 1995
25. Finnie NJ, Gottlieb TM, Blunt T, Jeggo PA, Jackson SP: DNA-dependant kinase activity is absent in xrs6 cells: Implications for site specific recombination and DNA double strand break repair. Proc Natl Acad Sci USA 92:320, 1995
26. Lees-Miller SP, Sakaguchi K, Ullrich S, Appella E, Anderson CW: Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 12:11, 1992
27. Blunt T, Finnie NJ, Taccioli GE, Smith CGM, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA, Jackson SP: Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80:813, 1995
28. Han Z, Johnston C, Reeves J, Carter T, Wyche JH, Hendrickson E: Characterization of a Ku 86 variant protein that results in altered DNA-binding and diminished DNA-dependent protein kinase activity. J Biol Chem 271:14098, 1996
29. Wang J, Chou CH, Blankson J, Satoh M, Knuth MW, Eisenberg RA, Pisetsky DS, Reeves WH: Murine monoclonal antibodies specific for conserved and non-conserved antigenic determinants of the human and murine Ku autoantigens. Mol Biol Rep 18:15, 1993
30. Carter T, Vancurova I, Sun I, Lou W, DeLeon S: A DNA-activated protein kinase from HeLa cell nuclei. Mol Cell Biol 10:6460, 1990
31. Muller C, Dusseau C, Calsou P, Salles B: Human normal peripheral blood B lymphocytes are defective in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku 86 protein. Oncogene 16:1553, 1998
32. Jongmans W, Artuso M, Vuillaume M, Brésil H, Jackson SP, Hall J: The role of Ataxia Telangiectasia and the DNA-dependent protein kinase in the p53-mediated cellular response to ionizing radiation. Oncogene 13:1133, 1996
33. Yaneva M, Jhiang J: Expression of the Ku protein during cell proliferation. Biochim Biophys Acta 1090:181, 1991
34. Cai QQ, Plet AA, Imbert J, Lafagepochitaloff M, Cerdan C, Blanchard JM: Chromosomal location and expression of the genes coding for Ku p70 and Ku p80 in human cell lines and normal tissues. Cytogen Cell Genet 65:221, 1994
35. Satoh M, Ajmani AK, Chou CH, Wang J, Reeves WH: Role of free p70 (Ku) subunit in posttranslational stabilization of newly synthetised p80 during DNA dependent protein kinase assembly. Eur J Cell Biol 66:127, 1995
36. Dörmer P, Thelm H, Lau B: Chronic lymphocytic leukemia: A proliferative or a accumulative disorder? Leuk Res 7:1, 1983
37. Kimby E, Mellstedt H, Nillson B, Tribukait B, Björkholm M, Holm G: S phase lymphocytes in chronic lymphocytic leukemia (CLL) in relation to immunoglobulin isotypes on the leukemic clone and to disease activity. Leukemia 1:432, 1987
38. Christodoulopoulos G, Muller C, Salles B, Kazmi R, Panasci L: Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-PK activity using wortmannin. Cancer Res 58:1789, 1998